Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vedolizumab and lymphocyte trafficking in pouchitis
NL-OMON49464Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of vedolizumab in pouchitis (3 arms), sponsored by Amsterdam University Medical Center. Started Jul 2017; status: completed.
02
Drugs
vedolizumab
03
Conditions
pouchitis
Beyond the preview
Go deeper on NL-OMON49464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49464.